STERIS Net Long-Term Debt 2010-2025 | STE

STERIS annual/quarterly net long-term debt history and growth rate from 2010 to 2025. Net long-term debt can be defined as the net amount of long term debt issued and repaid. This field is either calculated as the sum of the long term debt fields or used if a company does not report debt issued and repaid separately
  • STERIS net long-term debt for the quarter ending March 31, 2025 was $-0.718B, a 1096.88% increase year-over-year.
  • STERIS net long-term debt for the twelve months ending March 31, 2025 was $-2.633B, a 1655% increase year-over-year.
  • STERIS annual net long-term debt for 2025 was $-0.718B, a 1096.88% increase from 2024.
  • STERIS annual net long-term debt for 2024 was $-0.06B, a 75.79% decline from 2023.
  • STERIS annual net long-term debt for 2023 was $-0.248B, a 144.08% decline from 2022.
STERIS Annual Net Long-Term Debt
(Millions of US $)
2025 $-718
2024 $-60
2023 $-248
2022 $562
2021 $515
2020 $N/A
2019 $-85
2018 $-223
2017 $121
2016 $257
2015 $N/A
2014 $-70
2013 $200
2012 $N/A
2011 $N/A
2010 $N/A
2009 $109
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $23.975B $5.460B
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $199.668B 87.45
Thermo Fisher Scientific (TMO) United States $151.715B 18.35
Edwards Lifesciences (EW) United States $45.473B 29.82
Alcon (ALC) Switzerland $43.302B 29.26
IDEXX Laboratories (IDXX) United States $42.214B 48.51
DexCom (DXCM) United States $33.984B 52.53
IQVIA Holdings (IQV) United States $26.351B 14.76
Mettler-Toledo (MTD) United States $24.614B 29.27
Waters (WAT) United States $20.898B 29.49
SONOVA HOLDING (SONVY) Switzerland $18.583B 0.00
Hologic (HOLX) United States $14.336B 15.58
Sysmex ADR (SSMXY) Japan $10.191B 28.91
Penumbra (PEN) United States $10.026B 78.69
Masimo (MASI) United States $9.324B 34.39
Globus Medical (GMED) United States $8.112B 19.33
Teleflex (TFX) United States $5.426B 8.96
Glaukos (GKOS) United States $5.314B 0.00
TransMedics (TMDX) United States $4.703B 102.24
Integer Holdings (ITGR) United States $4.233B 22.18
PROCEPT BioRobotics (PRCT) United States $3.481B 0.00
LivaNova (LIVN) United Kingdom $2.505B 14.92
Veracyte (VCYT) United States $2.151B 30.18
Nihon Kohden (NHNKY) Japan $2.052B 23.53
Elekta AB (EKTAY) Sweden $1.975B 17.76
Alphatec Holdings (ATEC) United States $1.861B 0.00
Tandem Diabetes Care (TNDM) United States $1.384B 0.00
Artivion (AORT) United States $1.236B 115.80
Pulse Biosciences (PLSE) United States $1.150B 0.00
OPKO Health (OPK) United States $1.079B 0.00
Integra LifeSciences Holdings (IART) United States $1.054B 5.60
Beta Bionics (BBNX) United States $0.827B 0.00
SiBone (SIBN) United States $0.805B 0.00
IRadimed (IRMD) United States $0.769B 39.03
RxSight (RXST) United States $0.611B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.576B 8.96
Delcath Systems (DCTH) United States $0.570B 0.00
Mesa Laboratories (MLAB) United States $0.567B 13.30
OrthoPediatrics (KIDS) United States $0.515B 0.00
AxoGen (AXGN) United States $0.497B 0.00
AngioDynamics (ANGO) United States $0.449B 0.00
NeuroPace (NPCE) United States $0.431B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.430B 0.00
ClearPoint Neuro (CLPT) United States $0.390B 0.00
Semler Scientific (SMLR) United States $0.368B 9.79
Treace Medical Concepts (TMCI) United States $0.365B 0.00
Pacific Biosciences Of California (PACB) United States $0.342B 0.00
908 Devices (MASS) United States $0.249B 0.00
Neuronetics (STIM) United States $0.245B 0.00
Tactile Systems Technology (TCMD) United States $0.233B 14.14
Sight Sciences (SGHT) United States $0.217B 0.00
Alpha Tau Medical (DRTS) Israel $0.213B 0.00
Biosig Technologies (BSGM) United States $0.200B 0.00
Inogen (INGN) United States $0.177B 0.00
Spectral Diagnostics (EDTXF) Canada $0.173B 0.00
CVRx (CVRX) United States $0.171B 0.00
Anteris Technologies Global (AVR) Australia $0.171B 0.00
Rapid Micro Biosystems (RPID) United States $0.161B 0.00
LENSAR (LNSR) United States $0.155B 0.00
Lucid Diagnostics (LUCD) United States $0.140B 0.00
Accuray (ARAY) United States $0.133B 0.00
Atossa Genetics (ATOS) United States $0.116B 0.00
Microbot Medical (MBOT) United States $0.102B 0.00
Monogram Orthopaedics (MGRM) United States $0.091B 0.00
Sensus Healthcare (SRTS) United States $0.081B 49.20
InspireMD (NSPR) United States $0.077B 0.00
EnVVeno Medical (NVNO) United States $0.067B 0.00
EDAP TMS S.A (EDAP) France $0.067B 0.00
Hyperfine (HYPR) United States $0.062B 0.00
Positron (POSC) United States $0.052B 0.00
Spectral AI (MDAI) United States $0.051B 0.00
Vicarious Surgical (RBOT) United States $0.045B 0.00
Precision Optics (POCI) United States $0.036B 0.00
Envoy Medical (COCH) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.031B 0.00
Baird Medical Investment Holdings (BDMD) $0.030B 0.00
Adagio Medical Holdings (ADGM) United States $0.020B 0.00
NexGel (NXGL) United States $0.018B 0.00
WORK Medical Technology Group (WOK) China $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Ekso Bionics Holdings (EKSO) United States $0.010B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.009B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Venus Concept (VERO) Canada $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Accelerate Diagnostics (AXDX) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.29
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00